NURS 6501 Advanced Pathophysiology – Module 4: Respiratory System (Week 5) Study Notes

Topics: Asthma, COPD, Acute Respiratory Distress Syndrome (ARDS), Pulmonary HypertensionModule Overview: Module 4 (typically Week 5) examines alterations in pulmonary function, focusing on obstructive and restrictive lung diseases, acute life-threatening conditions, and vascular pulmonary disorders. Emphasis is on gas exchange impairments, inflammatory processes, ventilation-perfusion (V/Q) mismatch, and compensatory mechanisms (e.g., hypoxic pulmonary vasoconstriction). This module often includes cardiopulmonary interactions (e.g., cor pulmonale in chronic respiratory disease) and builds toward the midterm (frequently covering Weeks 1–6).Primary Textbook Reference: McCance, K. L., & Huether, S. E. (Latest edition, e.g., 9th). Pathophysiology: The Biologic Basis for Disease in Adults and Children. Elsevier. Key Chapter: Chapter 27: Alterations of Pulmonary Function (core for adult respiratory disorders: asthma, COPD, ARDS, pulmonary vascular diseases).
Related: Chapter 26 (Structure and Function of the Pulmonary System), portions of Chapter 24 (cardiopulmonary links).

Learning Objectives (Typical for Week 5): Analyze pathophysiological mechanisms in obstructive/restrictive lung diseases and acute respiratory failure.
Differentiate asthma vs. COPD; acute vs. chronic processes.
Evaluate V/Q mismatch, hypoxemia/hypercapnia, and pulmonary hypertension development.
Link alterations to clinical manifestations and advanced practice implications (e.g., oxygen therapy risks, exacerbation management).

1. Normal Pulmonary Structure and Function (Review Basics)Conducting vs. Respiratory Zones: Airways (trachea to terminal bronchioles) vs. gas exchange (respiratory bronchioles, alveoli).
Gas Exchange: Diffusion across alveolar-capillary membrane (Fick’s law: surface area, thickness, partial pressure gradient).
Ventilation-Perfusion (V/Q) Matching: Ideal ~0.8–1.0; gravity-dependent (apex high V/Q, base low V/Q).
Control of Breathing: Central (medulla/pons), peripheral chemoreceptors (carotid/aortic bodies – hypoxia, hypercapnia), lung receptors (stretch, irritant).
Pulmonary Circulation: Low-pressure, high-flow; hypoxic pulmonary vasoconstriction (HPV) redirects blood to better-ventilated areas.

2. AsthmaDefinition: Chronic inflammatory airway disease with reversible obstruction, bronchial hyperresponsiveness, and episodic symptoms.
Pathophysiology: Type I hypersensitivity (atopic) or non-atopic triggers → mast cell degranulation → histamine, leukotrienes → bronchoconstriction, edema, mucus hypersecretion.
Chronic: Eosinophilic inflammation, Th2 cytokines (IL-4, IL-5, IL-13), airway remodeling (subepithelial fibrosis, smooth muscle hypertrophy).
Obstruction: Early (bronchospasm), late (inflammation/mucus).

Clinical Manifestations: Wheezing, dyspnea, cough (nocturnal), chest tightness; reversible with bronchodilators.
Exacerbations: Triggers (allergens, infection, exercise); severe → status asthmaticus (life-threatening).
Compensatory: Tachypnea, accessory muscle use; chronic → air trapping → hyperinflation.
Nursing Implications: Stepwise management (GINA guidelines), trigger avoidance, inhaled corticosteroids (ICS), short-acting beta-agonists (SABA).

3. Chronic Obstructive Pulmonary Disease (COPD)Definition: Progressive, largely irreversible airflow limitation (FEV1/FVC <0.70 post-bronchodilator); includes chronic bronchitis and emphysema.
Pathophysiology: Primarily smoking → oxidative stress, protease-antiprotease imbalance (alpha-1 antitrypsin deficiency genetic risk).
Chronic bronchitis: Goblet cell hyperplasia → mucus hypersecretion → airway obstruction/infection.
Emphysema: Alveolar destruction → loss of elastic recoil → air trapping → hyperinflation → V/Q mismatch.
Small airway disease: Inflammation/fibrosis → fixed obstruction.

Clinical Manifestations: Dyspnea on exertion, chronic cough/sputum, wheeze, barrel chest (emphysema phenotype), frequent exacerbations.
Complications: Hypoxemia/hypercapnia → cor pulmonale (right ventricular hypertrophy/failure), polycythemia.
Compensatory: Increased respiratory drive, pursed-lip breathing, barrel chest to maintain FRC.
Nursing Implications: GOLD guidelines, smoking cessation, long-acting bronchodilators (LABA/LAMA), pulmonary rehab, exacerbation prevention (vaccines).

4. Acute Respiratory Distress Syndrome (ARDS)Definition: Acute, diffuse alveolar damage leading to non-cardiogenic pulmonary edema, severe hypoxemia (PaO2/FiO2 ≤300), bilateral infiltrates (Berlin criteria).
Pathophysiology: Direct (pneumonia, aspiration) or indirect (sepsis, trauma) insult → endothelial/epithelial injury → cytokine storm (TNF-α, IL-1, IL-6).
Exudative phase: Protein-rich edema, hyaline membranes, surfactant loss → atelectasis, decreased compliance.
Proliferative phase: Fibrosis risk.
Severe V/Q mismatch, shunting → refractory hypoxemia.

Clinical Manifestations: Rapid-onset dyspnea, tachypnea, cyanosis, crackles; mechanical ventilation often required.
Compensatory: Tachypnea initially; later respiratory muscle fatigue.
Nursing Implications: Low tidal volume ventilation (6 mL/kg PBW), PEEP, prone positioning, treat underlying cause.

5. Pulmonary Hypertension (PH)Definition: Mean pulmonary artery pressure (mPAP) ≥20–25 mmHg at rest (updated criteria).
Classification (WHO Groups): Group 1: PAH (idiopathic, heritable, connective tissue, drugs).
Group 2: Due to left heart disease.
Group 3: Due to lung disease/hypoxia (e.g., COPD, ILD).
Group 4: Chronic thromboembolic (CTEPH).
Group 5: Multifactorial.

Pathophysiology: Endothelial dysfunction → ↓ nitric oxide/prostacyclin, ↑ endothelin-1 → vasoconstriction.
Smooth muscle proliferation, intimal fibrosis → vascular remodeling → ↑ PVR.
Right ventricular strain → cor pulmonale.

Clinical Manifestations: Dyspnea, fatigue, syncope, chest pain, right heart failure signs (edema, JVD).
Nursing Implications: Vasodilators (e.g., sildenafil, bosentan for PAH), oxygen, anticoagulation (CTEPH), monitor RV function.

Key Comparisons TableObstructive (Asthma/COPD): Airway narrowing → expiratory limitation → hyperinflation.
Restrictive/Acute (ARDS): Alveolar filling → reduced compliance → hypoxemia dominant.
Vascular (PH): ↑ afterload on RV → cor pulmonale common in chronic lung disease.

Week 5 Graded Elements (Typical): Midterm Exam (often Week 5/6; covers Modules 1–4: cellular/genetics/neuro/cardio/respiratory; application-based).
Discussion: Respiratory alterations (e.g., cough types, COPD exacerbation).
Assignment: Case study analysis (e.g., COPD exacerbation with cardiopulmonary effects).

Study Strategies: Tables: Compare asthma vs. COPD (reversibility, inflammation type, phenotypes).
Diagrams: V/Q mismatch in COPD/ARDS; pulmonary vascular remodeling in PH.
Mnemonics: ARDS Berlin criteria (Acute, Bilateral, Respiratory failure, Not cardiac).
Focus on hypoxemia causes and treatments (e.g., O2 in COPD cautious due to hypoxic drive).

Collepals.com Plagiarism Free Papers

Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we'll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.

Get ZERO PLAGIARISM, HUMAN WRITTEN ESSAYS

Why Hire Collepals.com writers to do your paper?

Quality- We are experienced and have access to ample research materials.

We write plagiarism Free Content

Confidential- We never share or sell your personal information to third parties.

Support-Chat with us today! We are always waiting to answer all your questions.